WebApr 14, 2024 · HANGZHOU, China and SAN FRANCISCO, April 13, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative ... WebFeb 28, 2024 · HANGZHOU, China, Feb. 28, 2024 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd., (Sciwind), a clinical-stage, fast-growing biotech focusing on research and development of innovative...
Sciwind Biosciences Announces Positive Topline Results from 20-week P…
WebOct 12, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 12, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the closing of an $70 million Series C financing. The financing round was co … WebSciwind Total Funding $66.5 M Company summary Overview Sciwind (先为达是) is a biotech company that focuses on metabolic diseases, especially fibrotic diseases. It aims to develop therapeutic products for NASH, such as steatohepatitis, liver … counselors nashville
Sciwind Biosciences Announces Positive Interim Results from …
WebAug 3, 2024 · HANGZHOU, China and SAN FRANCISCO, Aug. 2, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on … WebSep 27, 2024 · SAN FRANCISCO, Calif. and HANGZHOU, China, Sept. 26, 2024 /PRNewswire/ -- Sciwind Biosciences, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies ... WebMar 1, 2024 · HANGZHOU, China, March 1, 2024 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd., (Sciwind), a clinical-stage, fast-growing biotech focusing on research and development of innovative biologics, today announced that XW003, a potential candidate for the treatment of non-alcoholic steatohepatitis (NASH), has been approved … counselors little rock ar